Urinary Tract Disorders and Nature-Based Management- A Comprehensive Review
Main Article Content
Abstract
Background: Urinary tract infections (UTIs) are becoming a serious public health issue affecting millions globally. The so-called uropathogens, which include Escherichia coli, Staphylococcus aureus, Enterococcus faecalis, Pseudomonas aeruginosa and Klebsiella pneumoniae are typically responsible for urinary tract infections, which are among the most prevalent infections in the majority of developing countries.
Objectives: The focus of this review paper was to outline natural treatment approaches for treating and curing UTIs.
Methods: To find the relevant publications, databases such as PubMed and Google Scholar were searched. Research articles, case studies, and review papers published between 1999 and 2025 were all included in the search approach.
Results: This study covers the epidemiology, pathogenesis, risk factors, various forms and conditions, and potential natural therapy options for UTIs. Withania somnifera, Tribulus terrestris, Asparagus racemosus, and Azadirachta indica are a few common medicinal herbs that have been shown to have therapeutic potential for the treatment and management of UTIs. Flowers, fruit, bark, leaves, seeds, and even entire portions of medicinal plants were used to treat urinary tract infections. These parts, or their extracts, are taken orally as a stand-alone preparation or may be combined with other foods or beverages, such as milk, honey, water, juices, black pepper etc.
Conclusion: Herbal remedies are effective both for short-term prophylaxis and at the earliest indication of an infection. Even though herbal remedies show more promise than conventional treatment, further research is needed to fully understand the phytoconstituents and how they work to treat and cure urinary tract infections.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
How to Cite
References
1.Shaheen G, Akram M, Jabeen F et al. Therapeutic potential of medicinal plants for the management of urinary tract infection: A systematic review. J. Clin. Pharmacol. 2019; 46(7):613-24.
2.Magtalas MC, Borja ML, Perez JR. Ethnomedicinal plants used for treating urinary tract infections in the Philippines: a systematic review. 2024
3.Meštrović T, Matijašić M, Perić M, et al. The role of gut, vaginal, and urinary microbiome in urinary tract infections: from bench to bedside. Diagnostics. 2020; 11(1):7.
4.Loubet P, Ranfaing J, Dinh A et al. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol. 2020; 11:1509.
5.Farrell K, Tandan M, Santiago VH et al. Treatment of uncomplicated UTI in males: a systematic review of the literature. BJGP open. 2021; 5(2).
6.Flores C, Rohn JL. Bacterial adhesion strategies and countermeasures in urinary tract infection. Nat. Microbiol. 2025; 10(3):627-45.
7.Mahalik G. A Review on Ethnobotanical Survey of Medicinal Plants used against Urinary Tract Infections. IJONS. 2020; 10(60).
8.Vasudevan R. Urinary tract infection: an overview of the infection and the associated risk factors. J Microbiol Exp. 2014; 1(2):00008.
9.Tama RT, Hossain MS, Rahaman MA et al. Harnessing the power of natural products against bacterial urinary tract infections: a perspective review for cultivating solutions. Health Sciences Review. 2024; 13:100199.
10.Kaur L. Plants and urinary tract infections: a critical review. J. Biodivers. Conservation. 2024; 8(3):45-58.
11.Flores-Mireles AL, Walker JN, Caparon M et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015; 13(5):269-84.
12.Sahu R, Sahoo RK et al. Urinary tract infection and its management. Sys Rev Pharm. 2019; 10(1):42-8.
13.Bhokardankar PS, Rathi B. Indigenous wisdom of Ayurvedic drugs to treat Urinary tract infections. INT J AYURVEDIC MED. 2020; 11(3):370-7.
14.Das S. Natural therapeutics for urinary tract infections—a review. Das S. Natural therapeutics for urinary tract infections—a review. Future J. Pharm. Sci. 2020 Sep 18;6(1):64. 2020; 6(1):64.
15.Fazly Bazzaz BS, Darvishi Fork S, Ahmadi R et al. Deep insights into urinary tract infections and effective natural remedies. Afr. j. urol. 2021 ;27(1):6.
16.Czajkowski K, Broś-Konopielko M, Teliga-Czajkowska J. Urinary tract infection in women. Menopause Rev. 2021; 20(1):40-7.
17.Oliveira EA, Mak RH. Urinary tract infection in pediatrics: an overview. J. Pediatr. 2020; 96:65-79.
18.Feyisa K, Feyisa W, Girma T et al. Traditional medicinal plants used for the treatment of urological and urogenital diseases in Ethiopia: a review. Pharmacogn J. 2022; 14(3).
19.Vaou N, Stavropoulou E, Voidarou C et al. Towards advances in medicinal plant antimicrobial activity: A review study on challenges and future perspectives. Microorganisms. 2021; 9(10):2041.
20.Ferdosh S. Ethnobotanical Review of Selected Medicinal Plants in Guam for the Treatment of Urinary Tract Ailments and Their Pharmacological Properties. Sci. Pharm. 2023 ;91(3):43.
21. Atkins L, Sallis A, Chadborn T et al. Reducing catheter-associated urinary tract infections: a systematic review of barriers and facilitators and strategic behavioural analysis of interventions. Implement. Sci. 2020; 15(1):44.
22. Tandoğdu Z, Bartoletti R, Cai T et al. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global 22.prevalence of infections in urology (GPIU) study 2003–2013. World J Urol. 2016; 34(8):1193-200.
23.Wagenlehner FM, Bjerklund Johansen TE, Cai T et al. Epidemiology, definition and treatment of complicated urinary tract infections. Nat. Rev. Urol. 2020; 17(10):586-600.
24.A‘t Hoen L, Bogaert G, Radmayr C et al. Update of the EAU/ESPU guidelines on urinary tract infections in children. J. Pediatr. Urol. 2021; 17(2):200-7.
25.Foxman B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 2010; 7(12):653-60.
26.Bermudez T, Schmitz JE, Boswell M et al. Novel technologies for the diagnosis of urinary tract infections. J Clin Microbiol. 2025; 63(2): e00306-24.
27.Zhou Y, Zhou Z, Zheng L et al. Urinary tract infections caused by uropathogenic Escherichia coli: mechanisms of infection and treatment options. Int. J. Mol. Sci. 2023; 24(13):10537.
28.Wen MM, Abdelwahab IA, Abozahra R et al. Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study. J. Nanobiotechnology. 2025; 23(1):174.
29.Codelia-Anjum A, Lerner LB, Elterman D et al. Enterococcal urinary tract infections: a review of the pathogenicity, epidemiology, and treatment. Antibiotics. 2023; 12(4):778.
30.Navidinia M, Mohammadi A, Arjmand R et al. Molecular typing, biofilm formation, and analysis of adhesion factors in Staphylococcus aureus strains isolated from urinary tract infections. Gene Rep. 2021; 22: 101008.
31.Vasudevan R. Emergence of UTI causing Staphylococcus aureus as a superbug: has the pathogen reduced the options of antimicrobial agents for treatment. EC Microbiol. 2015; 1:88-112.
32.Yuan F, Huang Z, Yang T et al. Pathogenesis of Proteus mirabilis in catheter-associated urinary tract infections. Urol Int. 2021;105(5-6):354-61.
33.Wasfi R, Hamed SM, Amer MA et al. Proteus mirabilis biofilm: development and therapeutic strategies. Front Cell Infect Microbiol. 2020; 10:414.
34.Morin CD, Déziel E, Gauthier J et al. An organ system-based synopsis of Pseudomonas aeruginosa virulence. Virulence. 2021; 12(1):1469-507.
35.AL-Khikani FH, Ayit AS. Pseudomonas Aeruginosa a tenacious uropathogen: Increasing challenges and few solutions. Biomed Biotechnol Res J. 2022; 6(3):311-8.
36.Chapelle C, Gaborit B, Dumont R et al. Treatment of UTIs due to Klebsiella pneumoniae carbapenemase-producers: how to use new antibiotic drugs? A narrative review. Antibiotics. 2021; 10(11):1332.
37.Effah CY, Sun T, Liu S et al. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020 Jan 9;19(1):1.
38.Odabasi Z, Mert A. Candida urinary tract infections in adults. World J. Urol. 2020; 38(11):2699-707.
39.Pakbin B, Brück WM, Rossen JW. Virulence factors of enteric pathogenic Escherichia coli: A review. Int. J. Mol. Sci. 2021; 22(18):9922.
40.Braz VS, Melchior K, Moreira CG. Escherichia coli as a multifaceted pathogenic and versatile bacterium. Front Cell Infect Microbiol. 2020; 10:548492.
41.Zagaglia C, Ammendolia MG, Maurizi L et al. Urinary tract infections caused by uropathogenic Escherichia coli strains—new strategies for an old pathogen. Microorganisms. 2022; 10(7):1425.
42.Guan L, Beig M, Wang L et al. Global status of antimicrobial resistance in clinical Enterococcus faecalis isolates: systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2024 Aug 24;23(1):80.
43.NI AH, Huycke MM. Enterococcal disease, epidemiology, and implications for treatment.2014.
44.Fayisa WO, Tuli NF. Review on Staphylococcus aureus. Int. J. Nurs. Care Res. 2023; 1:1-8.
45.Chakkour M, Hammoud Z, Farhat S, El Roz A, Ezzeddine Z, Ghssein G. Overview of Proteus mirabilis pathogenicity and virulence. Insights into the role of metal. Front. Microbiol. 2024; 15:1383618.
46.Qin S, Xiao W, Zhou C et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct. Target. Ther. 2022; 7(1):199.
47.Jasim ST, Farhan AS. Article review: Klebsiella pneumonia: Epidemiology, virulence factors and treatment. flora. 2020; 14(2):5-10.
48.Tan X, Baugh K, Bulman ZP et al. Review of the current management of urinary tract infections due to fluconazole-resistant and non-albicans Candida species. Curr. Fungal Infect. Rep. 2020; 14(3):268-78.
49.Talapko J, Juzbašić M, Matijević T et al. Candida albicans—the virulence factors and clinical manifestations of infection. J. Fungi. 2021; 7(2):79.
50.Wilson M, Wilson PJ. Close Encounters of the Microbial Kind. Cham: Springer Internat. Publ. 2021.
51.Dominoni M, Scatigno AL, La Verde M et al. Microbiota ecosystem in recurrent cystitis and the immunological microenvironment of urothelium. In Healthcare. 2023; 11(4):525.
52.Kwok M, McGeorge S, Mayer‐Coverdale J et al. Guideline of guidelines: management of recurrent urinary tract infections in women. BJU Int. 2022; 130:11-22.
53.Jhang JF, Jiang YH, Kuo HC. Current understanding of the pathophysiology and novel treatments of interstitial cystitis/bladder pain syndrome. Biomedicines. 2022; 10(10):2380.
54.Offiah I, McMahon SB, O’Reilly BA. Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J. 2013; 24(8):1243-56.
55.Park JJ, Kim KT, Lee EJ et al. Current updates relating to treatment for interstitial cystitis/bladder pain syndrome: systematic review and network meta-analysis. BMC Urol. 2024; 24(1):95.
56.Schwartz L, de Dios Ruiz-Rosado J, Stonebrook E et al. Uropathogen and host responses in pyelonephritis. Nat. Rev. Nephrol. 2023; 19(10):658-71.
57.Herness J, Buttolph A, Hammer NC. Acute pyelonephritis in adults: rapid evidence review. Am. Fam. Physician. 2020; 102(3):173-80.
58.Colgan R, Jaffe GA, Nicolle LE. Asymptomatic bacteriuria. Am. Fam. Physician. 2020; 102(2):99-104.
59. Blãnaru AM, Popa MI. ASYMPTOMATIC BACTERIURIA: DIAGNOSIS AND 59.MANAGEMENT. Roum. Arch. Microbiol. Immunol. 2024; 83(1).
60.Schneeberger C, Kazemier BM, Geerlings SE. Asymptomatic bacteriuria and urinary tract infections in special patient groups: women with diabetes mellitus and pregnant women. Curr. Opin. Infect. Dis. 2014; 27(1):108-14.
61.George CE, Norman G, Ramana GV et al. Treatment of uncomplicated symptomatic urinary tract infections: Resistance patterns and misuse of antibiotics. J. family med. prim. care. 2015; 4(3):416-21.
62.Rahman AJ, Naz F, Ashraf S. Significance of pyuria in the diagnosis of urinary tract infections in neonates. J. Pak. Med. Assoc. 2011; 61(1):70.
63.Stapleton A. Urinary tract infections in patients with diabetes. Am J Med. 2002; 113(1):80-4.
64.Melekos MD, Naber KG. Complicated urinary tract infections. Int. J. Antimicrob. Agents. 2000; 15(4):247-56.
65.Burrows LL. It’s uncomplicated: Prevention of urinary tract infections in an era of increasing antibiotic resistance. PLoS Pathog. 2024; 20(2): e1011930.
66.Mørkved S, Bø K. Prevalence of urinary incontinence during pregnancy and postpartum. Int. Urogynecology J. 1999; 10(6):394-8.
67.González-Chamorro F, Palacios R, Alcover J et al. Urinary tract infections and their prevention. Actas Urol. Esp. 2012; 36(1):48-53.
68.Beerepoot M, Geerlings S. Non-antibiotic prophylaxis for urinary tract infections. Pathogens. 2016; 5(2):36.
69.Reid G. Potential preventive strategies and therapies in urinary tract infection. World J. Urol. 1999; 17(6):359-63.
70.Hisano M, Bruschini H, Nicodemo AC et al. Cranberries and lower urinary tract infection prevention. Clinics. 2012; 67(6):661-7.
71.Lema VM, Lema AP. Sexual activity and the risk of acute uncomplicated urinary tract infection in premenopausal women: implications for reproductive health programming. Obstet. Gynecol. Int. J. 2018; 9(1):00303.
72.Chen YC, Lee WC, Chuang YC. Emerging non-antibiotic options targeting uropathogenic mechanisms for recurrent uncomplicated urinary tract infection. Int. J. Mol. Sci. 2023; 24(8):7055.
73.Kul'chavenya EV, Breusov AA, Kulchavenya EV. Efficacy of uro-vaxom in recurrent infectious-inflammatory diseases of the urogenital system. Urologiia. 2011; 15(4):7-11.
74.Brodie A, El-Taji O, Jour I et al. A retrospective study of immunotherapy treatment with Uro-Vaxom (OM-89®) for prophylaxis of recurrent urinary tract infections. Curr. Urol. 2020; 14(3):130-4.
75.Mak Q, Greig J, Dasgupta P et al. Promising efficacy of UTI vaccines as an alternative to antibiotics. Nat. Rev. Urol. 2024; 21(12):701-2.
76.Grin PM, Kowalewska PM, Alhazzan W et al. Lactobacillus for preventing recurrent urinary tract infections in women: meta-analysis. Can J Urol. 2013; 20(1):6607-14.
77.Farhana F, Mosaddek N, Mosaddek AS et al. Effectiveness of Probiotics for the Treatment of Urinary Tract Infection among Women in Bangladesh. Med. Res. J Vol. 3. 2024; 11:25-43.
78.Reid G. Probiotic therapy and functional foods for prevention of urinary tract infections: state of the art and science. Curr. Infect. Dis. Rep. 2000; 2(6):518-22.
79.Balusupati KK, Sura S, Pinneboina RP et al. Current therapies of urinary tract infections and prevention of multi drug resistance. Int. j. curr. innov. res. 2024.
80.Medina M, Castillo-Pino E. An introduction to the epidemiology and burden of urinary tract infections. Ther. Adv. Urol. 2019; 11:1756287219832172.
81.Lopez Romo A, Quirós R. Appropriate use of antibiotics: an unmet need. Ther. Adv. Urol. 2019; 11: 1756287219832174.
82.Sher EK, Džidić-Krivić A, Sesar A et al. Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections. Pharmacol. Ther. 2024; 261:108688.
83.Chaughule RS, Barve RS. Role of herbal medicines in the treatment of infectious diseases. In Infectious Diseases. 2024.
84.Das DC, Sinha NK, Patsa MK et al. Investigation of herbals for the treatment of leucorrhoea from south West Bengal, India. Int. J. Bioassays. 2015.
85.Pattanayak S, Das DC, Sinha NK et al. Use of medicinal plants for the treatment of urinary tract infections: a study from Paschim Medinipur district, West Bengal, India. Int J Pharma Bio Sci. 2017.
86.Jaradat NA, Zaid AN, Al-Ramahi R et al. Ethnopharmacological survey of medicinal plants practiced by traditional healers and herbalists for treatment of some urological diseases in the West Bank/Palestine. BMC Complement. Altern. Med. 2017; 17(1):255.
87.Paschal FB, Mwega ED, Bakari GG. Ethnobotanical Survey on Awareness of Medicinal Plants Used for Treatment of Urinary Tract Infection in Biharamulo District: Tanzania. European J Med Plants. 2023; 34(8):21-40.
88.Arsene MM, Viktorovna PI, Davares AK et al. Urinary tract infections: Virulence factors, resistance to antibiotics, and management of uropathogenic bacteria with medicinal plants: A review. J. Appl. Pharm. Sci. 2021; 11(7):001-12.
89.Divya PV, Sukesh K. An Ethnobotanical Survey on Medicinal Plants used to treat Urinary Tract Infections in Kanyakumari District. J Phytopharmacol. 2023; 12(4):235-239.
90.Kacholi DS, Charwi MZ, Mogha NG. Ethnomedicinal study of medicinal plants used for treatment of urinary tract infections in Mara region, Tanzania. Ethnobot. Res. Appl. 2023; 26:1-4.
91.Mahalik G, Satapathy KB, Sahoo S. Ethnobotanical survey of plants used in treatment of urinary disorders in Dhenkanal district of Odisha, India. J Environ Sci Toxicol Food Technol. 2015; 9(8):58-63.
92.Taibi K, Aït Abderrahim L, Boussaid M et al. Unraveling the ethnopharmacological potential of medicinal plants used in Algerian traditional medicine for urinary diseases. Eur. J. Integr. Med. 2021; 44:101339.
93.Tripathy SR, Dash J, Das S. Medico-ethnobotanical studies of Odisha state, India for urogenital disorders: a review. TMR Integr Med. 2021; 5: e21028.
94.Saleh RH, Omran AM, AlHilla RS. Traditional plants that are utilized to treat urinary tract infections: A review. Maaen j. med. sci. 2023; 2(1):1.
95. Sen UK, Bhakat RK. Ethnobotanical study on sand-dune based medicinal plants and traditional therapies in coastal Purba Medinipur District, 95.West Bengal, India. European J Med Plants. 2018; 26(2):1-9.
96.Sahu D, Sahu JK, Kumar V et al. Phytochemicals and medicinal uses of Clitoria ternatea. Int J Plant Soil Sci. 2023; 35(18):942-51.
97.Kam SE, Meda RN, Kabre Z et al. Ethnobotanical survey of plants used by traditional healers for treatment of urinary infections in Hauts-Bassins Areas of Burkina Faso. Int. J. Sci. Res. 2020; 9(5):1113-8.
98.Ahmed OA, Afifi MM. Efficacy of Aqueous, Ethanolic and Ethyl acetate Extracts of Curcuma longa in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections. J. Environ. Stud. 2022; 27(1):1-9.
99.Fatima A, Malik T, Ibrahim I et al. Phytochemical screening and antibacterial activity of neem extracts on uropathogens. Pure Appl. Bio. 2020; 9(1):148-53.
100.Karuppasamy V, Kannan S. In vitro efficacy of phytotherapeutics for the prevention of urinary tract infections in pregnant women. Indian J Biochem Biophys. 2024; 61(3):182-9.
101.Rathore DS, Sharma N. ANTIBACTERIAL EFFECTS OF ETHANOLIC EXTRACT OF SARACA ASOCA LEAVES ON HUMAN PATHOGEN WITH SPECIAL REFERENCE TO ESCHERICHIA COLI AND STAPHYLOCOCCUS AUREUS. World J. Pharm. Res. 2018.
102.Mohamad LS. The effect of alcoholic extracts of zingiberofficinale anti-E. coli isolates isolated from urinary tract infection. Iraqi J. Sci. 2019; 60(10):2136-40.
103.Lakshmi CS, Uma A, Prakasham RS, Jayalaxmi L, Chandrasekhar N. Phytochemical Analysis and Antimicrobial Potential of Abutilon indicum Stem Extracts against GUTI Pathogens. Curr. trends. biotechnol. pharm. 2014; 8(2):192-203.
104.Singh N, Mishra S, Jain N et al. Antimicrobial potential of selected arid and semi-arid plants against urinary tract infection causing pathogens through GC-MS and FTIR analysis. Int. J. Appl. Sci. Eng. 2023.
105.Hussein HM, Hameed RH, Hameed IH. Screening of bioactive Compounds of Ricinus communis Using GC-MS and FTIR and Evaluation of its antibacterial and antifungal activity. Indian J. Public Health Res. Dev. 2018; 9(5):467-73.
106.Arsene MM, Viktorovna PI, Sergei GV et al. Phytochemical analysis, antibacterial and antibiofilm activities of Aloe vera aqueous extract against selected resistant gram-negative bacteria involved in urinary tract infections. Fermentation. 2022; 8(11):626.
107.Arodes ES, Cing JM, Sitompul F et al. Effectiveness of Methanol Extract of Moringa oleifera Lam. Leaf as Antibacterial Drug to Bacterial Triggers of Urinary Tract Infections In vitro. J. complement. altern. med. res. 2022; 17(1):1-2.
108.Sharma R, Godatwar P. In Vitro Anti-microbial effect of various extracts of Ġokṣura (Tribulus terrestris) fruits on common pathogens causing Urinary Tract Infection. J. ayurveda integr. med. sci. 2022; 7(9):64-9.
109. RH A, VV S, Oommen SM. Clinical trial on the efficacy of root powder of Asparagus 109.racemosus Willd. (shatavari) in urinary tract infection. Int. res. j. pharm. med. sci. 2018.
110.Akanmu AO, Yunus HH, Balogun ST et al. Antibacterial Activity of Aqueous and Ethanol Fruit Extracts of Cucumis sativus Linn. Against Selected Microorganisms at the University of Maiduguri Teaching Hospital, Maiduguri. Sahel J. Vet. Sci. 2021; 18(2):17-22.
111.Deshpande BS, Deshpande AS, Maldhure AK. Aegle Marmelos Corr., Cynodon Dactylon Pers. and Datura Inoxia Mill.
112.Mahalik GY, Sahoo SA, Satapathy KB. Evaluation of phytochemical constituents and antimicrobial properties of Mangifera indica L. Leaves against urinary tract infection-causing pathogens. Evaluation. 2017; 10(9):169.
113.Nisa I, Tareen AR, Hannan PA et al. Antibacterial Activity Of Allium Sativum Extract Against Staphylococcus Aureus and Escherichia Coli: A Phytochemical Approach. Journal of Medical & Health Sciences Review. 2025; 2(1).
114.Ilangage JI, Ilangakoon IA, Fernando KM et al. In vitro-antibacterial properties of ten medicinal plants against common uropathogenic organisms and toxicity determination using brine shrimp lethality assay. BMC complement. med. ther. 2024; 24(1):301.
115.Sundararajan G, Ananthi S, Vijayakumar AR et al. Evaluation of In-Vitro Anti-Urolithiatic Activity of Achyranthes Aspera. J. Pharm. Negat. Results. 2022; 2140-2144.
116.Dhanasekaran S, Rajesh A, Mathimani Tet al. Efficacy of crude extracts of Clitoria ternatea for antibacterial activity against gram negative bacterium (Proteus mirabilis). Biocatal Agric Biotechnol. 2019; 21:101328.
117.Dev SN, De K, Singh S. Antimicrobial activity and phytochemical analysis of Acacia nilotica (L.) Del. Indian J Appl Pure Bio. 2014; 29(2):331-2.
118.Saleh BH, Ibrahim RN, Abdul-Wahed HE et al. Study the antibacterial activity of green tea leaves Camellia sinensis ethanolic extract against different pathogenic bacteria isolated from urinary tract infections. Plant Archives. 2020; 20(1):1077-84.
119.Odelola OS, Oyetayo VO, Ogundare AO et al. Antibacterial activity of zea mays silks and husks crude extract on biofilm producing multi-drug resistant bacteria from urinary catheters. Int J Pathog Res. 2023; 12(2):37-51.
120.Shaw A, Mishra S, Dutta D. Comparative anti-microbial study of alcoholic extract of hibiscus rosa-sinesis with marketed formulation. World J. Pharm. Res. 2020.
121.Hammadi AA, Abed HA, Rabie ZH. Effect extraction of nigella sativa and malricaia chamoilla on urinary tract infection. Sci J Med Res. 2020; 4(16):118-24.
122.Sharma N, Rathore DS. Antibacterial effects of Citrus limon peel extract on human pathogenic bacteria with special reference to Urinary Tract Infection. Int. J. Sci. Res. 2018; 5:2.
123.Kumar S, Parikh P, Gupta HN. Indian medicinal plants for combating urinary tract infections.
124.Chakrabarty S, Sahoo M, Mishra MP et al. Impact of Some Ethnomedicinal Plants Extracts Against Screened MDR Strains Isolated from UTI Patients Population of a Tertiary Care Centre in Eastern India. Int. Res. J. Multidiscip. Scope. 2024.
125.Maddala VK. Traditional Herbs as Effective Natural Remedies for Treating Urinary Tract Ailments. Curr trends biotechnol pharm. 2025; 19(1):2212-22.
126.Ndlazi ZM, Mvubu NE, De Gama BZ. A review of documented antimicrobial and immunomodulatory properties of six selected ethnomedicinal plants, used as a concoction by traditional health practitioners for the management of urinary tract infections, in the region of KwaZulu-Natal, South Africa. S. Afr. J. Bot. 2025; 176: 170-83.
127.Sharif A, Ali A, Amjad M et al. Therapeutic potential of Cydonia oblonga extracts for anti-urease and antibacterial activities to cure urinary tract infections. J. Agric. Food Res. 2025; 19:101590.